Prediction of response to splenectomy in patients with idiopathic thrombocytopenic purpura

被引:30
作者
Shojaiefard, A. [1 ]
Mousavi, S. A. [2 ]
Faghihi, S. H. [1 ]
Abdollahzade, S. [3 ,4 ]
机构
[1] Univ Tehran, Sch Med, Shariati Hosp, Dept Surg, Tehran, Iran
[2] Univ Tehran, Sch Med, Shariati Hosp, Dept Hematol & Oncol, Tehran, Iran
[3] Univ Tehran, Dept Surg, Shariati Hosp, Sch Med, Tehran, Iran
[4] Univ Tehran, SSRC, Tehran, Iran
关键词
D O I
10.1007/s00268-007-9399-2
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background Chronic immune thrombocytopenic purpura (ITP) is an autoimmune disorder characterized by destruction of opsonized platelets in the reticuloendothelial system, particularly the spleen, and by resulting low platelet counts. Splenectomy is the standard second-line treatment for patients with ITP who do not respond to corticosteroids. In the present study we determined predictive factors for the response of patients with ITP to splenectomy. Materials and Methods For thirty-one patients with ITP referred from the Hematology Department of Shariati Hospital, open surgical splenectomy was performed between February 2002 and December 2004. All potentially important variables of response were collected and analyzed to determine predictive parameters. Results Older patients (> 52) responded less positively than younger patients (< 52) to splenectomy (p < 0.01). Likewise, patients with a sustained remission after splenectomy had a significantly shorter interval of diagnosis of ITP to splenectomy (p < 0.05) and shorter duration of corticosteroid therapy before splenectomy (p < 0.05). Conclusions This study confirms that splenectomy is an effective treatment for patients with ITP. Our findings highlight age as the major predictive factor of long-term response to splenectomy in patients with ITP.
引用
收藏
页码:488 / 493
页数:6
相关论文
共 42 条
[1]   Idiopathic thrombocytopenic purpura -: A retrospective analysis in 139 patients of the influence of age on the response to corticosteroids, splenectomy and danazol [J].
Andrès, E ;
Zimmer, J ;
Noel, E ;
Kaltenbach, G ;
Koumarianou, A ;
Maloisel, F .
DRUGS & AGING, 2003, 20 (11) :841-846
[2]  
Beardsley Diana S, 2006, Hematology Am Soc Hematol Educ Program, P402
[3]   Laparoscopic surgery - 15 years after clinical introduction [J].
Bittner, Reinhard .
WORLD JOURNAL OF SURGERY, 2006, 30 (07) :1190-1203
[4]  
Bresler L, 2002, WORLD J SURG, V26, P111
[5]  
Bussel J, 2006, SEMIN HEMATOL, V43, pS18
[6]   Treatment of immune thrombocytopenic purpura in adults [J].
Bussel, James .
SEMINARS IN HEMATOLOGY, 2006, 43 (03) :S3-S10
[7]  
Chen CC, 2001, HAEMATOLOGICA, V86, P663
[8]  
Choi CW, 2001, AM J HEMATOL, V66, P197, DOI 10.1002/1096-8652(200103)66:3<197::AID-AJH1044>3.3.CO
[9]  
2-Y
[10]   Medical progress: Immune thrombocytopenic purpura. [J].
Cines, DB ;
Blanchette, VS .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (13) :995-1008